𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of ureteral stone disease: the role of ESWL and endourology

✍ Scribed by K. Miller; G. Fuchs; J. Rassweiler; F. Eisenberger

Publisher
Springer-Verlag
Year
1985
Tongue
English
Weight
694 KB
Volume
3
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ESWL and the future of stone management
ESWL and the future of stone management
✍ F. Eisenberger; A. Schmidt πŸ“‚ Article πŸ“… 1993 πŸ› Springer-Verlag 🌐 English βš– 565 KB

Based on optimal efficacy regarding disintegration and stone clearance, combined with minimal invasiveness, extracorporeal shockwave lithotripsy (ESWL) represents the first choice therapy for urolithiasis. Further developments in ESWL have related more to economic aspects than to improvement of disi

The effect of stones on renal and ureter
The effect of stones on renal and ureteric physiology
✍ P. G. Horgan; A. A. Sarazen; G. M. Lennon; J. M. Fitzpatrick πŸ“‚ Article πŸ“… 1993 πŸ› Springer-Verlag 🌐 English βš– 685 KB

The effect of calculi on renal and ureteric function is the result of a complex sequence of pathophysiological events triggered by obstruction. The degree of impairment of renal function resulting depends on whether the obstruction is partial or complete, is unilateral or bilateral, is complicated b

Treatment of renal calcium stone disease
Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate
✍ B. FellstrΓΆm; U. Backman; B. Danielson; B. WikstrΓΆm πŸ“‚ Article πŸ“… 1994 πŸ› Springer-Verlag 🌐 English βš– 255 KB

Glycosaminoglycans (GAGs) are potent inhibitors of calcium oxalate growth and aggregation. The synthetic G A G pentosan polysulphate (PPS) was used in the treatment of patients with renal calcium stone disease. Altogether, 121 patients were included in an open trial over a 3-year-period. The averag